The results of our meta-analysis did not indicate any significant association between the GSTP1 Ile105Val polymorphism and the risk of gynecological cancer, both in the overall study population and in the stratified subgroup analyses. This evidence concerns the gene GSTP1 and female reproductive organ cancer.